Sofosbuvir Impurity 19

Sofosbuvir Impurity 19 Suppliers list
Company Name: ANHUI WITOP BIOTECH CO., LTD
Tel: +8615255079626
Email: eric@witopchemical.com
Products Intro: Product Name:D-Alanine Sofosbuvir
CAS:1064684-71-4
Company Name: sgtlifesciences pvt ltd
Tel: +8617013299288
Email: dj@sgtlifesciences.com
Products Intro: Product Name:SFB-D-Alaninate
CAS:1064684-71-4
Company Name: Shanghai Payne Pharmaceutical Technology Co.Ltd
Tel: 021-58123769 18678586262
Email: info@paynepharm.com
Products Intro: Product Name:sofosbuvir impurity-15
CAS:1064684-71-4
Purity:95+% HPLC Package:10mg;25mg;50mg;100mg
Company Name: Varanous Labs Pvt Ltd  
Tel: +91-7036248882 +91-7036248882
Email: bheemashankar.e@varanouslabs.com
Products Intro: Product Name:SFB-D-Alanite
CAS:1064684-71-4
Purity:98% Package:1 kg,5 kg, 10 kg,25kg and 1 MT
Company Name: Guangzhou PI PI Biotech Inc  
Tel: 020-81716320 +86-13602409664
Email: Sales@pipitech.com
Products Intro: Product Name:Sofosbuvir Impurity 19
CAS:1064684-71-4
Purity:90%+ Package:10mg, 25mg, 50mg, 100mg, Other scale please email Sales@pipitech.com Remarks:D-Alanine Sofosbuvir
Sofosbuvir Impurity 19 Basic information
Product Name:Sofosbuvir Impurity 19
Synonyms:D-Alanine Sofosbuvir;(R)-2-{[(2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-ylmethoxy](phenoxy)phosphorylamino}propionic acid isopropyl ester;SFB-D-Alaninate;Sofosbuvir D-AlaninateQ: What is Sofosbuvir D-Alaninate Q: What is the CAS Number of Sofosbuvir D-Alaninate Q: What is the storage condition of Sofosbuvir D-Alaninate Q: What are the applications of Sofosbuvir D-Alaninate;D-Alanine, N-[(2'R)-2'-deoxy-2'-fluoro-2'-methyl-P-phenyl-5'-uridylyl]-, 1-methylethyl ester;SFB-D-ALANITE
CAS:1064684-71-4
MF:C22H29FN3O9P
MW:529.4525242
EINECS:
Product Categories:
Mol File:1064684-71-4.mol
Sofosbuvir Impurity 19 Structure
Sofosbuvir Impurity 19 Chemical Properties
density 1.41±0.1 g/cm3(Predicted)
pka9.39±0.10(Predicted)
Safety Information
MSDS Information
Sofosbuvir Impurity 19 Usage And Synthesis
UsesD-Alanine Sofosbuvir?is a useful reagent for synthesizing?β-D-2''-Deoxy-2''-α-fluoro-2''-β-C-methyluridine nucleotide that can selectively inhibit Hepatitis C virus (HCV) NS5B polymerase, which is a potential target for developing therapies for HCV.?D-Alanine Sofosbuvir?is also an impurity of Sofosbuvir (P839640).
Sofosbuvir Impurity 19 Preparation Products And Raw materials
Tag:Sofosbuvir Impurity 19(1064684-71-4) Related Product Information
Sofosbuvir IMpurity PSI-6130 derivative Sofosbuvir Impurity Sofosbuvir D6 Exemestane Impurity 13 Cytidine, N-benzoyl-2^-deoxy-2^-Methylene-,3^,5^-dibenzoate(9CI) PSI-7977-13C-d3 Sofosbuvir metabolites GS566500 Sofosbuvir metabolites PSI 352707-13C,D3 2'-deoxy-2'-fluoro-2'-C-methyluridine PSI-7976 Cytidine,N-benzoyl-2^-C-Methyl-,3^,5^-dibenzoate(9CI) Sofosbuvir Impurity 32 PSI-6206 13CD3 Sofosbuvir Impurity 8 1-((2R,3S,4R,5R)-3,4-dihydroxy-5-(hydroxyMethyl)-3-Methyltetrahydrofuran-2-yl)pyriMidine-2,4(1H,3H)-dione PSI 7411

  • HomePage | Member Companies | Advertising | Contact us | Previous WebSite | MSDS | CAS Index | CAS DataBase | Privacy | Terms | About Us
  • All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.
    According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.
  • Copyright © 2023 ChemicalBook All rights reserved.
This site uses cookies
This website uses cookies and similar technologies to store and retrieve information about your use of this website. This information helps us to provide, analyse and improve our services, which may include personalised content or advertising. We may share this information with Google and other third parties. This cookies are necessary for our website to work properly . By clicking "Continue" or continuing to browse our site you are agreeing to our and our partners use of cookies.
Accept